Irina Antonijevic
Chairman of the R&D Committee
R & D
Paion
Germany
Biography
Dr. Irina Antonijevic is a member of PAION’s Supervisory Board since May 2017. Dr. Dr. Irina Antonijevic joined vasopharm GmbH in 2016 as Chief Medical Officer. She has more than 16 years of tdrug developmen experience in different pharmaceutical organizations, with a focus on neuropsychiatric and rare diseases. In her last role at Sanofi Genzyme in Cambridge (MA, USA), she oversaw multiple innovative clinical programs as Global Head Early Development Neurology and Ophthalmology. She completed her medical studies at the Technical University of Munich (1991), received her MD from the Max Planck Institute in Munich (1992) and her PhD from the University of Edinburgh, UK (1995). She completed her residency at the Max Planck Institute of Psychiatry in Munich and received her Venia Legendi from the Charité, Berlin, in 2004. Dr. Dr. Antonijevic has been a regular reviewer for the German Ministry of Research (BMBF) since 2006.
Research Interest
Drug developmen
